
Fischer Medical Ventures Gets CDSCO Approval for Spincare Wound Care System
Fischer Medical Ventures Ltd. announced that its associate company, Nanomedic Technologies Ltd., has received import and distribution approval from India's CDSCO for the Spincare Portable Wound Care System. This is India's first regulatory clearance for a portable electrospun wound care system. Spincare, a Class C medical device, applies a nano-fiber film directly to wounds, eliminating traditional dressings in many cases. The approval positions Fischer Medical Ventures to capitalize on India's growing wound care market, valued at approximately USD 380 million in 2026 and projected to reach USD 1.8 billion by 2033. Fischer holds exclusive distribution rights for India and Southeast Asia. Nanomedic also has a U.S. FDA approval submission in progress.
Key Highlights
- CDSCO import approval received for Spincare portable wound care system.
- First regulatory clearance in India for a portable electrospun wound care device.
- Fischer Medical Ventures to distribute Spincare in India and Southeast Asia.
- India's wound care market projected to reach USD 1.8 billion by 2033.
- Associate company Nanomedic has US FDA approval submission underway.
Price Impact
More from FISCHER
More in Regulatory